Quick Answer
ENANTA PHARMACEUTICALS INC reported Net Income of -$81.89 million for fiscal year 2025.
ENANTA PHARMACEUTICALS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$81.89M | +29.4% |
| 2024 | -$116.05M | +13.3% |
| 2023 | -$133.82M | -9.9% |
| 2022 | -$121.75M | -54.1% |
| 2021 | -$79.00M | -118.4% |
| 2020 | -$36.17M | -178.0% |
| 2019 | $46.38M | -35.5% |
| 2018 | $71.96M | +306.3% |
| 2017 | $17.71M | -18.3% |
| 2016 | $21.67M | -72.6% |
| 2015 | $78.99M | +129.4% |
| 2014 | $34.44M | +257.7% |
| 2013 | $9.63M | -55.0% |
| 2012 | $21.40M | -8.2% |
| 2011 | $23.31M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$11.94M | +46.4% | +34.6% |
| June 30, 2025 | -$18.25M | +19.4% | +19.4% |
| March 31, 2025 | -$22.64M | +27.3% | -1.6% |
| December 31, 2024 | -$22.29M | +33.3% | +1.6% |
| June 30, 2024 | -$22.66M | +42.0% | +27.3% |
| March 31, 2024 | -$31.16M | +17.3% | +6.7% |
| December 31, 2023 | -$33.41M | -15.3% | +14.5% |
| June 30, 2023 | -$39.06M | -23.2% | -3.7% |
- ENANTA PHARMACEUTICALS INC showed an increase of +29.4% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, ENANTA PHARMACEUTICALS INC’s net income has declined by 451.3% (from $23.31 million to -$81.89 million).
- The most recent figure is from ENANTA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 19, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: